CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,032,885
- in 7 filings, $3.7M under 10b5-1 plans
Net −$4,032,885. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Gilbert Halley E Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2026-06-15 | Lukatch Heath Director | Grant or award | +2,265 | 19,481 | ||
| 2026-06-15 | Lukatch Heath Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2026-06-15 | BRANDICOURT OLIVIER Director | Grant or award | +2,194 | 4,699 | ||
| 2026-06-15 | BRANDICOURT OLIVIER Director | Grant or award · Stock Option (right to buy) | +11,034 | 11,034 | ||
| 2026-06-15 | Drapeau Anne S Director | Grant or award | +2,265 | 12,481 | ||
| 2026-06-15 | Drapeau Anne S Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2026-06-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,949 | $49.40 | $96K | 158,795 |
| 2026-06-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −301 | $50.26 | $15K | 158,494 |
| 2026-05-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,250 | $56.83 | $128K | 160,744 |
| 2026-04-07 | Cowan Elvia SVP, Finance & CAO | Option exercise 10b5-1 | +3,000 | $25.92 | $78K | 31,975 |
| 2026-04-07 | Cowan Elvia SVP, Finance & CAO | Sale 10b5-1 | −3,000 | $60.00 | $180K | 28,975 |
| 2026-04-07 | Cowan Elvia SVP, Finance & CAO | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 93,068 | ||
| 2026-04-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,412 | $58.14 | $82K | 165,406 |
| 2026-04-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −838 | $58.93 | $49K | 162,994 |
| 2026-03-17 | Cowan Elvia SVP, Finance & CAO | Sale 10b5-1 | −1,487 | $55.39 | $82K | 29,380 |
| 2026-03-17 | Cowan Elvia SVP, Finance & CAO | Sale 10b5-1 | −405 | $56.26 | $23K | 28,975 |
| 2026-03-11 | Cowan Elvia SVP, Finance & CAO | Option exercise 10b5-1 | +2,500 | $25.92 | $65K | 33,367 |
| 2026-03-11 | Cowan Elvia SVP, Finance & CAO | Sale 10b5-1 | −2,500 | $58.59 | $146K | 30,867 |
| 2026-03-11 | Cowan Elvia SVP, Finance & CAO | Option exercise · Stock Option (right to buy) 10b5-1 | −2,500 | 96,068 |
Page 6 of 16 · 319 trades